Dr. Sofya Kostanyan, MD

Dr. Kostanyan practices at Nyu Langone Hospital-Brooklyn-Cardiac Catheterization Lab - HOPD in Brooklyn, New York.

Dr. Kostanyan's NPI, 1578726337, was assigned on July 2, 2008. Dr. Kostanyan graduated from Ross University School of Medicine in 2007. Dr. Kostanyan's New York license number on file is 259081.

Dr. Kostanyan's primary practice is Nyu Langone Hospital-Brooklyn-Cardiac Catheterization Lab - HOPD, at 150 55th St, Brooklyn, NY 11220.

Dr. Kostanyan's primary practice is Nyu Langone Hospital-Brooklyn-Cardiac Catheterization Lab - HOPD in Brooklyn, New York. Dr. Kostanyan is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Kostanyan to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kostanyan practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kostanyan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kostanyan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kostanyan has a license on file in New York.

Dmand AI lists acute diabetes, anemia, cardiac arrhythmia, cellulitis, cerebrovascular disease, chronic hypertension, circulatory problems in extremities and collapsed lung among the conditions Dr. Kostanyan treats.

CMS data shows 1,249 Medicare services from Dr. Kostanyan across 6 procedure codes in 2024, for 367 Medicare patients. Medicare paid $116,652 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 367 Medicare patients who saw Dr. Kostanyan in 2024. The largest group is 75 to 84, with 134 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kostanyan's median patient age at 73, with 56% women.

In 2024, Dr. Kostanyan wrote 244 Medicare Part D claims for 67 patients. 78% of them were for generic drugs. CMS names the drug for 60 of them, across 3 drugs with 11 or more claims each, at $459 in total drug cost. In 2023, CMS named 64 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kostanyan for performance year 2024, reported as part of a group. Dr. Kostanyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kostanyan as offering telehealth.

Dmand AI links 3 papers to Dr. Kostanyan, published from 2022 to 2023. 2023 was the busiest year, with 2. Dr. Kostanyan has published most often in Cureus. Dr. Kostanyan's most frequent co-author is Franklin Kasmin, MD.

CMS Open Payments shows 5 general payments to Dr. Kostanyan from 3 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $234.

Dr. Kostanyan graduated from Ross University School of Medicine in 2007. Dr. Kostanyan is a member of ACP.

Dr. Kostanyan is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.